Resources with keywords: covid-19



Laboratory Biosafety Guidelines for working with SARS-CoV-2 (NEW 4/20, Website, Regulatory)
CDC

Emphasizes this guidance is specific to SARS-CoV-2 and does not apply to other Corona Viruses

The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24 (NEW 2/10, Website, Publication)
The Lancet - Infectious Diseases
29 January 2025

P Bager, et al.
An observational study comparing the severity of COVID-19 and influenza among nearly 6 million Denmark residents finds a higher rate of hospitalizations and deaths in those infected with SARS-CoV-2—mainly among unvaccinated people, those with chronic conditions, and males—from 2022 to 2024.

Wastewater Monitoring Dashboard for Canada (NEW 1/11, Website, Regulatory)
Governement of Canada- National Collaboration Centre for Infectious Diseases

This dashboard provides data about COVID-19, flu, RSV and mpox virus levels in wastewater.

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised (NEW 11/11, Website, News)
CDC Newsroom
23 October 2024

CDC endorsing that people 65 years and older and those who are moderately or severely immunocompromised receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.

Strategies for Conserving the Supply of N95® Filtering Facepiece Respirators (Website, Regulatory)
CDC / NIOSH

Key Points include strategies for contingency capacity

Infection Control Guidance: SARS-CoV-2 (Website, Regulatory)
CDC
18 March 2024

This guidance applies to all U.S. settings where healthcare is delivered, including nursing homes and home health. The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency.

Providing Clarity Regarding the Regulation of Respirators Used in Health Care Settings (NEW 9/14, Website, Publication, Regulatory)
CDC / NIOSH Science Blog
15 July 2024

Currently there remains a lack of regulatory alignment among OSHA, the Food and Drug Administration (FDA), and the National Institute for Occupational Safety and Health (NIOSH) regarding respirator approval for use in health care.

Interim Guidelines for Biosafety and COVID-19 (Website, Regulatory)
CDC
10 July 2024

This guidance is intended for clinical laboratory and support staff who handle or process specimens associated with COVID-19.

Long COVID Basics (NEW 7/8, Website, Regulatory)
CDC

Discusses the disease, prevention via vaccination, signs and symptoms, complications, testing and diagnosis, who is most at risk, etc.

The COVID pandemic spurred a revision of US pathogen research rules. Will it help? (NEW 7/8, Website, News)
Bulletin of the Atomic Scientists
17 June 2024

Gillum D, et al.
The US government issued a long-awaited policy update last month intended to better manage the hazards associated with risky biological research.

Go to Top